Inventor
HARRIMAN WILLIAM DON
US31 patents
⚠️ This page may combine multiple inventors who share the name “HARRIMAN WILLIAM DON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRYSTAL BIOSCIENCE INC
25 patentsUS8030095B2Oct 4, 2011
Gel microdrop composition and method of using the same
CRYSTAL BIOSCIENCE INC34 citations92
US9982062B2May 29, 2018
In vivo method for generating diversity in a protein scaffold
CRYSTAL BIOSCIENCE INC5 citations84
US9394372B2Jul 19, 2016
In vivo method for generating diversity in a protein scaffold
CRYSTAL BIOSCIENCE INC8 citations84
US10687519B2Jun 23, 2020
Transgenic animal for production of antibodies having minimal CDRs
CRYSTAL BIOSCIENCE INC3 citations83
US10172334B2Jan 8, 2019
Transgenic animal for production of antibodies having minimal CDRS
CRYSTAL BIOSCIENCE INC4 citations83
US9809642B2Nov 7, 2017
Transgenic chicken comprising an inactivated immunoglobulin gene
CRYSTAL BIOSCIENCE INC7 citations83
US9549538B2Jan 24, 2017
Transgenic animal for production of antibodies having minimal CDRs
CRYSTAL BIOSCIENCE INC4 citations83
US9404125B2Aug 2, 2016
Transgenic animal for production of antibodies having minimal CDRs
CRYSTAL BIOSCIENCE INC6 citations82
US11602136B2Mar 14, 2023
In vivo method for generating diversity in a protein scaffold
CRYSTAL BIOSCIENCE INC1 citations73
US10555508B2Feb 11, 2020
In vivo method for generating diversity in a protein scaffold
CRYSTAL BIOSCIENCE INC3 citations73
US11337409B2May 24, 2022
Transgenic animal for producing diversified antibodies that have the same light chain I
CRYSTAL BIOSCIENCE INC4 citations72
US11033009B2Jun 15, 2021
Transgenic chicken for production of antibodies having a common light chain
CRYSTAL BIOSCIENCE INC5 citations72
US10689433B2Jun 23, 2020
Transgenic chicken comprising an inactivated immunoglobulin gene
CRYSTAL BIOSCIENCE INC2 citations72
US12568940B2Mar 10, 2026
Transgenic chicken having an endogenous immunoglobulin heavy chain gene in which the IgY CH1 coding sequence is functionally deleted
CRYSTAL BIOSCIENCE INC0 citations62
US12543710B2Feb 10, 2026
Transgenic animal for producing diversified antibodies that have the same light chain II
CRYSTAL BIOSCIENCE INC0 citations62
US12408640B2Sep 9, 2025
Transgenic animal for producing diversified antibodies that have the same light chain I
CRYSTAL BIOSCIENCE INC0 citations62
US11542319B2Jan 3, 2023
Transgenic chicken comprising an inactivated immunoglobulin gene
CRYSTAL BIOSCIENCE INC0 citations62
US10010058B2Jul 3, 2018
Transgenic animal for production of antibodies having minimal CDRS
CRYSTAL BIOSCIENCE INC1 citations62
US12441802B2Oct 14, 2025
Anti-B7-H3 antibody and methods of use thereof
CRYSTAL BIOSCIENCE INC0 citations56
US12583930B2Mar 24, 2026
Human glucose-dependent insulinotropic polypeptide receptor (GIPR) antibodies and methods of use thereof to inhibit GIP receptor and signaling
CRYSTAL BIOSCIENCE INC0 citations54
US12588664B2Mar 31, 2026
Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion
CRYSTAL BIOSCIENCE INC0 citations51
US12428471B2Sep 30, 2025
Transgenic chicken that makes antibodies with long CDR-H3S stabilized by multiple disulfide bridges and diversified by gene conversion
CRYSTAL BIOSCIENCE INC0 citations51
US12102070B2Oct 1, 2024
Camelization of a human variable domain by gene conversion
CRYSTAL BIOSCIENCE INC0 citations51
US10362770B2Jul 30, 2019
Transgenic animal for production of antibodies having minimal CDRs
CRYSTAL BIOSCIENCE INC0 citations51
US12534537B2Jan 27, 2026
Anti-CD38 antibody and methods of use thereof
CRYSTAL BIOSCIENCE INC0 citations45
ALX ONCOLOGY INC
3 patentsUS11401338B2Aug 2, 2022
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC6 citations84
US11242404B2Feb 8, 2022
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC3 citations71
US12404340B2Sep 2, 2025
Antibodies against signal-regulatory protein alpha and methods of use
ALX ONCOLOGY INC0 citations61